HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: fj.07-105221v1 22/7/2198    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flierl, M. A. Articles by Ward, P. A. Search for Related Content PubMed PubMed Citation Articles by Flierl, M. A. Articles by Ward, P. A.

Adverse functions of IL-17A in experimental sepsis

Michael A. Flierl^*,1, Daniel Rittirsch^*,1, Hongwei Gao^,1, Laszlo M. Hoesel^*, Brian A. Nadeau^*, Danielle E. Day^*, Firas S. Zetoune^*, J. Vidya Sarma^*, Markus S. Huber-Lang, James L. M. Ferrara and Peter A. Ward^*,2

^* Department of Pathology, and

Departments of Pediatrics and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA;

Department of Biochemistry and Molecular Biology, University of North Dakota Medical School, Grand Forks, North Dakota, USA; and

Department of Traumatology, Hand- and Reconstructive Surgery, University of Ulm Medical School, Ulm, Germany

²Correspondence: Department of Pathology, The University of Michigan Medical School, 1301 Catherine Rd., Ann Arbor, MI 48109-0602, USA. E-mail: pward{at}umich.edu

IL-17A is a proinflammatory cytokine produced by a variety of cells. In the current study, we examined the role of IL-17A in sepsis induced in mice by cecal ligation and puncture (CLP). IL-17A levels, which rose time-dependently in plasma after CLP, were not affected in the absence of β T cells or neutrophils. In sharp contrast, T cell-knockout or T cell-depleted mice displayed baseline IL-17A plasma levels after CLP. Neutralization of IL-17A by two different antibodies improved sepsis (survival from 10% to nearly 60%). Unexpectedly, antibody treatment was protective, even when administration of anti-IL-17A was delayed for up to 12 h after CLP. These protective effects of IL-17A blockade were associated with substantially reduced levels of bacteremia together with significant reductions of systemic proinflammatory cytokines and chemokines in plasma. In vitro incubation of mouse peritoneal macrophages with lipopolysaccharide (LPS) in the copresence of IL-17A substantially increased the production of TNF-, IL-1β, and IL-6 by these cells. These data suggest that, during experimental sepsis, T cell-derived IL-17A promotes high levels of proinflammatory mediators and bacteremia, resulting in enhanced lethality. IL-17A may be a potential therapeutic target in sepsis.—Flierl, M. A., Rittirsch, D., Gao, H., Hoesel, L. M., Nadeau, B. A., Day, D. E., Zetoune, F. S., Sarma, J. V., Huber-Lang, M. S., Ferrara, J. L. M., Ward, P. A. Adverse functions of IL-17A in experimental sepsis.

Key Words: • T cells • survival • colony-forming units • cytokines • chemokines

This article has been cited by other articles:

				G. Sellge, J. G. Magalhaes, C. Konradt, J. H. Fritz, W. Salgado-Pabon, G. Eberl, A. Bandeira, J. P. Di Santo, P. J. Sansonetti, and A. Phalipon Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective Immunity J. Immunol., February 15, 2010; 184(4): 2076 - 2085. [Abstract] [Full Text] [PDF]

				X. Zhou, Q. Chen, J. Moore, J. K. Kolls, S. Halperin, and J. Wang Critical Role of the Interleukin-17/Interleukin-17 Receptor Axis in Regulating Host Susceptibility to Respiratory Infection with Chlamydia Species Infect. Immun., November 1, 2009; 77(11): 5059 - 5070. [Abstract] [Full Text] [PDF]

				Q.-T. Nguyen, S.-A Ju, S.-M. Park, S.-C. Lee, H. Yagita, I. H. Lee, and B.-S. Kim Blockade of CD137 Signaling Counteracts Polymicrobial Sepsis Induced by Cecal Ligation and Puncture Infect. Immun., September 1, 2009; 77(9): 3932 - 3938. [Abstract] [Full Text] [PDF]

				A. Freitas, J. C. Alves-Filho, T. Victoni, T. Secher, H. P. Lemos, F. Sonego, F. Q. Cunha, and B. Ryffel IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis J. Immunol., June 15, 2009; 182(12): 7846 - 7854. [Abstract] [Full Text] [PDF]

				U. Maitra, S. Davis, C. M. Reilly, and L. Li Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-1 J. Immunol., May 1, 2009; 182(9): 5763 - 5769. [Abstract] [Full Text] [PDF]

				N. Takahashi, I. Vanlaere, R. de Rycke, A. Cauwels, L. A.B Joosten, E. Lubberts, W. B. van den Berg, and C. Libert IL-17 produced by Paneth cells drives TNF-induced shock J. Exp. Med., August 4, 2008; 205(8): 1755 - 1761. [Abstract] [Full Text] [PDF]